Sargent Investment Group, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.15 - $0.37 $17,775 - $43,845	-118,500 Reduced 3.28%	3,492,000 $558,000
Q1 2024 May 10, 2024	SELL	$0.19 - $0.3 $39,425 - $62,250	-207,500 Reduced 5.43%	3,610,500 $974,000
Q4 2023 Feb 05, 2024	SELL	$0.12 - $0.64 $12,600 - $67,200	-105,000 Reduced 2.68%	3,818,000 $839,000
Q2 2023 Jul 31, 2023	SELL	$0.35 - $0.72 $115,149 - $236,880	-329,000 Reduced 7.74%	3,923,000 $1.41 Million
Q1 2023 May 02, 2023	SELL	$0.39 - $0.6 $51,884 - $79,822	-133,037 Reduced 3.03%	4,252,000 $2 Million
Q4 2022 Jan 31, 2023	BUY	$0.46 - $42.69 $81,742 - $7.59 Million	177,700 Added 4.22%	4,385,037 $2.19 Million
Q3 2022 Oct 26, 2022	BUY	$0.63 - $33.0 $155,255 - $8.13 Million	246,437 Added 6.22%	4,207,337 $2.9 Million
Q2 2022 Jul 26, 2022	BUY	$0.63 - $0.96 $199,660 - $304,244	316,921 Added 8.7%	3,960,900 $3.13 Million
Q1 2022 May 06, 2022	BUY	$0.5 - $1.06 $7,536 - $15,977	15,073 Added 0.42%	3,643,979 $2.93 Million
Q4 2021 Feb 11, 2022	BUY	$0.92 - $1.22 $353,174 - $468,339	383,885 Added 11.83%	3,628,906 $3.67 Million
Q3 2021 Nov 12, 2021	BUY	$0.67 - $1.51 $703,918 - $1.59 Million	1,050,625 Added 47.88%	3,245,021 $4.22 Million
Q2 2021 Aug 05, 2021	BUY	$0.75 - $1.1 $139,053 - $203,944	185,404 Added 9.23%	2,194,396 $1.7 Million
Q1 2021 May 04, 2021	BUY	$0.96 - $1.74 $556,281 - $1.01 Million	579,460 Added 40.53%	2,008,992 $2.11 Million
Q4 2020 Feb 10, 2021	BUY	$0.76 - $1.47 $499,355 - $965,859	657,047 Added 85.06%	1,429,532 $1.94 Million
Q3 2020 Nov 12, 2020	BUY	$0.67 - $0.96 $306,816 - $439,617	457,935 Added 145.58%	772,485 $592,000
Q2 2020 Aug 11, 2020	BUY	$0.52 - $0.92 $63,700 - $112,700	122,500 Added 63.79%	314,550 $246,000
Q1 2020 May 12, 2020	BUY	$0.6 - $2.31 $81,720 - $314,622	136,200 Added 243.87%	192,050 $115,000
Q4 2019 Jan 30, 2020	BUY	$0.63 - $2.27 $35,185 - $126,779	55,850 New	55,850 $127,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $119M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account